219 related articles for article (PubMed ID: 11744033)
1. Inhibition of vascular smooth muscle cell proliferation by a novel fibroblast growth factor receptor antagonist.
Segev A; Aviezer D; Safran M; Gross Z; Yayon A
Cardiovasc Res; 2002 Jan; 53(1):232-41. PubMed ID: 11744033
[TBL] [Abstract][Full Text] [Related]
2. Porphyrin analogues as novel antagonists of fibroblast growth factor and vascular endothelial growth factor receptor binding that inhibit endothelial cell proliferation, tumor progression, and metastasis.
Aviezer D; Cotton S; David M; Segev A; Khaselev N; Galili N; Gross Z; Yayon A
Cancer Res; 2000 Jun; 60(11):2973-80. PubMed ID: 10850445
[TBL] [Abstract][Full Text] [Related]
3. Platelet-derived growth factor-BB-induced human smooth muscle cell proliferation depends on basic FGF release and FGFR-1 activation.
Millette E; Rauch BH; Defawe O; Kenagy RD; Daum G; Clowes AW
Circ Res; 2005 Feb; 96(2):172-9. PubMed ID: 15625285
[TBL] [Abstract][Full Text] [Related]
4. Heparin-induced overexpression of basic fibroblast growth factor, basic fibroblast growth factor receptor, and cell-associated proteoheparan sulfate in cultured coronary smooth muscle cells.
Skaletz-Rorowski A; Schmidt A; Breithardt G; Buddecke E
Arterioscler Thromb Vasc Biol; 1996 Aug; 16(8):1063-9. PubMed ID: 8696947
[TBL] [Abstract][Full Text] [Related]
5. Heparan sulphate glycosaminoglycans derived from endothelial cells and smooth muscle cells differentially modulate fibroblast growth factor-2 biological activity through fibroblast growth factor receptor-1.
Berry D; Shriver Z; Natke B; Kwan CP; Venkataraman G; Sasisekharan R
Biochem J; 2003 Jul; 373(Pt 1):241-9. PubMed ID: 12659634
[TBL] [Abstract][Full Text] [Related]
6. Ethanol inhibits fibroblast growth factor-induced proliferation of aortic smooth muscle cells.
Ghiselli G; Chen J; Kaou M; Hallak H; Rubin R
Arterioscler Thromb Vasc Biol; 2003 Oct; 23(10):1808-13. PubMed ID: 12907464
[TBL] [Abstract][Full Text] [Related]
7. Laminarin sulfate mimics the effects of heparin on smooth muscle cell proliferation and basic fibroblast growth factor-receptor binding and mitogenic activity.
Miao HQ; Ishai-Michaeli R; Peretz T; Vlodavsky I
J Cell Physiol; 1995 Sep; 164(3):482-90. PubMed ID: 7650058
[TBL] [Abstract][Full Text] [Related]
8. The chemotactic and mitogenic effects of platelet-derived growth factor-BB on rat aorta smooth muscle cells are inhibited by basic fibroblast growth factor.
Facchiano A; De Marchis F; Turchetti E; Facchiano F; Guglielmi M; Denaro A; Palumbo R; Scoccianti M; Capogrossi MC
J Cell Sci; 2000 Aug; 113 ( Pt 16)():2855-63. PubMed ID: 10910770
[TBL] [Abstract][Full Text] [Related]
9. Counter-regulatory function of protein tyrosine phosphatase 1B in platelet-derived growth factor- or fibroblast growth factor-induced motility and proliferation of cultured smooth muscle cells and in neointima formation.
Chang Y; Ceacareanu B; Zhuang D; Zhang C; Pu Q; Ceacareanu AC; Hassid A
Arterioscler Thromb Vasc Biol; 2006 Mar; 26(3):501-7. PubMed ID: 16373608
[TBL] [Abstract][Full Text] [Related]
10. Heparin inhibits the binding of basic fibroblast growth factor to cultured human aortic smooth-muscle cells.
Bono F; Rigon P; Lamarche I; Savi P; Salel V; Herbert JM
Biochem J; 1997 Sep; 326 ( Pt 3)(Pt 3):661-8. PubMed ID: 9307014
[TBL] [Abstract][Full Text] [Related]
11. Heparan sulfate proteoglycans function as receptors for fibroblast growth factor-2 activation of extracellular signal-regulated kinases 1 and 2.
Chua CC; Rahimi N; Forsten-Williams K; Nugent MA
Circ Res; 2004 Feb; 94(3):316-23. PubMed ID: 14684627
[TBL] [Abstract][Full Text] [Related]
12. Vascular cell-derived heparan sulfate shows coupled inhibition of basic fibroblast growth factor binding and mitogenesis in vascular smooth muscle cells.
Nugent MA; Karnovsky MJ; Edelman ER
Circ Res; 1993 Dec; 73(6):1051-60. PubMed ID: 8222077
[TBL] [Abstract][Full Text] [Related]
13. Cytotoxic effects of basic FGF and heparin binding EGF conjugated with cytotoxin saporin on vascular cell cultures.
Chen C; Li J; Micko CJ; Pierce GF; Cunningham MR; Lumsden AB
J Surg Res; 1998 Feb; 75(1):35-41. PubMed ID: 9614854
[TBL] [Abstract][Full Text] [Related]
14. Syndecan-4 is required for thrombin-induced migration and proliferation in human vascular smooth muscle cells.
Rauch BH; Millette E; Kenagy RD; Daum G; Fischer JW; Clowes AW
J Biol Chem; 2005 Apr; 280(17):17507-11. PubMed ID: 15731100
[TBL] [Abstract][Full Text] [Related]
15. Heparin-binding epidermal growth factor-like growth factor regulates fibroblast growth factor-2 expression in aortic smooth muscle cells.
Peifley KA; Alberts GF; Hsu DK; Feng SL; Winkles JA
Circ Res; 1996 Aug; 79(2):263-70. PubMed ID: 8756003
[TBL] [Abstract][Full Text] [Related]
16. Thrombin- and factor Xa-induced DNA synthesis is mediated by transactivation of fibroblast growth factor receptor-1 in human vascular smooth muscle cells.
Rauch BH; Millette E; Kenagy RD; Daum G; Clowes AW
Circ Res; 2004 Feb; 94(3):340-5. PubMed ID: 14670838
[TBL] [Abstract][Full Text] [Related]
17. Activation of integrin receptors is required for growth factor-induced smooth muscle cell dysfunction.
Mawatari K; Liu B; Kent KC
J Vasc Surg; 2000 Feb; 31(2):375-81. PubMed ID: 10664505
[TBL] [Abstract][Full Text] [Related]
18. Kinetic model for FGF, FGFR, and proteoglycan signal transduction complex assembly.
Ibrahimi OA; Zhang F; Hrstka SC; Mohammadi M; Linhardt RJ
Biochemistry; 2004 Apr; 43(16):4724-30. PubMed ID: 15096041
[TBL] [Abstract][Full Text] [Related]
19. A synthetic heparin-mimicking polyanionic compound binds to the LDL receptor-related protein and inhibits vascular smooth muscle cell proliferation.
Benezra M; Vogel T; Ben-Sasson SA; Panet A; Sehayek E; Al-Haideiri M; Decklbaum RJ; Vlodavsky I
J Cell Biochem; 2001; 81(1):114-27. PubMed ID: 11180402
[TBL] [Abstract][Full Text] [Related]
20. Heparan sulfate proteoglycans control intracellular processing of bFGF in vascular smooth muscle cells.
Sperinde GV; Nugent MA
Biochemistry; 1998 Sep; 37(38):13153-64. PubMed ID: 9748322
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
